Victoria Vakiener
Director/Board Member at CHIMERIX, INC.
Net worth: 915 229 $ as of 2024-03-30
Profile
Victoria Vakiener is an Independent Director at Arrowhead Pharmaceuticals, Inc. and Chimerix, Inc. She previously worked as Vice President at Janssen Pharmaceuticals, Inc., Chief Commercial Officer at Epizyme, Inc., and Vice President-Oncology Marketing at Janssen Oncology, Inc. She completed her undergraduate degree at Albright College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-10 | 32,001 ( 0.03% ) | 915 229 $ | 2024-03-30 | |
CHIMERIX, INC.
-.--% | 2023-06-08 | 0 ( -.--% ) | - $ | 2024-03-30 |
Victoria Vakiener active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIX, INC. | Director/Board Member | 2021-04-25 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2022-05-01 |
Former positions of Victoria Vakiener
| Companies | Position | End |
|---|---|---|
| EPIZYME, INC. | Corporate Officer/Principal | 2021-09-30 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 2020-08-31 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 2018-11-30 |
Training of Victoria Vakiener
| Albright College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Victoria Vakiener
